Research progress and therapeutic strategies in hepatocellular carcinoma metabolic reprogramming

Haibo Wang, Yu Lun, Dongdong Xu, Han Jiang, Y. H. Yan, Xing YangJournal of Advanced Research 2025 · DOI

Abstract

Metabolism reprogramming is closely associated with HCC proliferation and metastasis, while the interplay between metabolic pathways further drives disease progression. Targeting key metabolic enzymes and pathways through combination therapies and novel drug development shows promising clinical potential. This review provides a comprehensive analysis of metabolic reprogramming in HCC and underscores the importance of understanding these mechanisms to develop more effective therapeutic interventions.
BibTeX
@article{wang2025research,
  author = {Haibo Wang and Yu Lun and Dongdong Xu and Han Jiang and Y. H. Yan and Xing Yang},
  title = {{Research progress and therapeutic strategies in hepatocellular carcinoma metabolic reprogramming}},
  journal = {Journal of Advanced Research},
  year = {2025},
  doi = {10.1016/j.jare.2025.08.023},
}

Loading related content...

Figure